{
    "eid": "2-s2.0-85135229692",
    "title": "Prognostic factors in completely resected lymph-node-negative pulmonary adenocarcinoma",
    "cover-date": "2022-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Early-stage lung cancer",
        "EGFR mutation",
        "lymph node-negative",
        "prognostic factors",
        "recurrence"
    ],
    "authors": [
        "Nussara Pakvisal",
        "Poonchavist Chantranuwat",
        "Chanida Vinayanuwattikun",
        "Piyada Sitthideatphaiboon",
        "Chinachote Teerapakpinyo",
        "Shanop Shuangshoti",
        "Vichai Benjacholamas",
        "Nopporn Pornpattanarak",
        "Virote Sriuranpong"
    ],
    "citedby-count": 0,
    "ref-count": 30,
    "ref-list": [
        "Cancer statistics, 2013",
        "Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group",
        "Relapse in resected lung cancer revisited: does intensified follow up really matter? A prospective study",
        "Prognosis of recurrence after complete resection in early-stage non-small cell lung cancer",
        "Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage",
        "The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma",
        "Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma",
        "Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer",
        "Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables",
        "Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer",
        "Arterial invasion predicts early mortality in stage I non-small cell lung cancer",
        "Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups",
        "A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)",
        "Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma",
        "Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer",
        "The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers",
        "Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib",
        "Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan",
        "The 7th lung cancer TNM classification and staging system: Review of the changes and implications",
        "The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications",
        "Toxicity and response criteria of the Eastern Cooperative Oncology Group",
        "The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification",
        "Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients",
        "A simulation study of the number of events per variable in logistic regression analysis",
        "The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures",
        "Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases",
        "High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand",
        "The proximal extension of carcinoma of the lung in the bronchial wall",
        "Bronchial resection margin length and clinical outcome in non-small cell lung cancer",
        "Bronchial resection margin and long-term survival in non-small-cell lung cancer"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn Academic Advancement",
        "Ratchadapiseksompotch Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}